Header Logo

Connection

NICOLA HANANIA to Receptors, Interleukin-4, Type II

Back to Details
This is a "connection" page, showing publications NICOLA HANANIA has written about Receptors, Interleukin-4, Type II.
NICOLA HANANIA
Connection Strength
0.045
Receptors, Interleukin-4, Type II
  1. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2020 11; 125(5):565-576.e1.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.